A5005676689- Global Cancer Incidence and Screening
- Lung Cancer Treatments and Mutations
- Cervical Cancer and HPV Research
- Lung Cancer Diagnosis and Treatment
- Advances in Oncology and Radiotherapy
- Cardiac tumors and thrombi
- Inflammatory Biomarkers in Disease Prognosis
- Digital Imaging for Blood Diseases
- Multiple and Secondary Primary Cancers
- Colorectal Cancer Screening and Detection
- Esophageal and GI Pathology
- Urologic and reproductive health conditions
- Genetic factors in colorectal cancer
- Lung Cancer Research Studies
- Cancer Diagnosis and Treatment
- Advanced Radiotherapy Techniques
- Endometrial and Cervical Cancer Treatments
- Esophageal Cancer Research and Treatment
- Sarcoma Diagnosis and Treatment
Addis Ababa University
2015-2025
Tikur Anbessa Hospital
2015-2024
Addis Ababa City Administration Health Bureau
2021
There are limited population-based survival data for colorectal cancer (CRC) in sub-Saharan Africa. Here, 1707 persons diagnosed with CRC from 2005 to 2015 were randomly selected 13 registries operating 11 countries Vital status was ascertained medical charts or through next of kin. 1-, 3- and 5-year overall relative rates all each registry calculated using the Kaplan-Meier estimator. Multivariable analysis used examine associations age at diagnosis, stage country-level Human Development...
Abstract Background: Cervical cancer is the second leading cause of death among women in Addis Ababa and other parts Ethiopia. Yet, there are limited age-eligible city-wide data on cervical screening prevalence to inform public policy. Methods: A population-based cross-sectional study was conducted 1881 eligible aged 30-49 years who were selected from 63 enumeration areas based multistage sampling proportional sample size allocation. Logistic regression used identify barriers screening. All...
Lung cancer is the most common cause of deaths worldwide, accounting for 1.8 million each year. Only 20% lung cases are reported to occur in low- and middle-income countries. An estimated 1.5% all Ethiopian cancers involved lung; however, no nationwide registry exists Ethiopia. Thus, accurate data on clinical history, histopathology, molecular characteristics, risk factors not available. The aim this study was describe clinical, radiologic, pathologic including available profiles, at Tikur...
PURPOSE Nonmetastatic cervical cancer is curable and can be treated with radiotherapy (RT). A delay in receiving treatment because of long waiting times results upstaging the disease stage negatively affects outcomes. However, real-world evidence that progression occurs while for scarce low-income countries. We evaluated impact RT patients at a referral center Ethiopia. METHODS longitudinal study was conducted from January 5, 2019, to May 30, 2020, address objectives this study. Patients...
LMS of IVC needs a multidisciplinary approach. Surgical excision with free margin is the cornerstone management. Upon case-by-case selection, adjuvant chemotherapy may play role in better oncologic outcome.
Abstract Background: Breast cancer is among the leading causes of death in women. Different socio-demographic factors have impact on early diagnosis and treatment breast cancer. Hematological abnormalities are also some conditions to be monitored during Objective: To describe socio demographic hematologic profile patients with at Tikur Anbessa Specialized Hospital. Methods: C ase control study was conducted from May 2018 June 2019. A total 230 cases controls participated study. Descriptive...
e16520 Background: There is little information on treatment and survival of cervical cancer (CC) in developing countries. We evaluated pts who received radiotherapy at Addis Ababa University Hospital, the only center Ethiopia. Methods: All with CC (2008–2012) were eligible. Pts external radiation according to FIGO stage adapted guidelines (no Brachytherapy). Data was obtained from clinical records telephone contact. used multivariable Cox proportional hazards regression estimate adjusted...
ABSTRACT Nonmetastatic cervical cancer is a highly curable malignancy, and radiotherapy (RT) remains the mainstay treatment. Early initiation critical, optimal time to initiate RT for cure 6 weeks, with reported 15% decrease in 3-year overall survival those who wait 40 days. There considerable variation waiting between countries, median of 27.2 days Ontario, Canada 108 South Africa. Real-world evidence progression because treatment delay scarce low-income countries. Ethiopia, country 120...